analyst
AM
NASDAQ · AMLX
Amylyx Pharmaceuticals, Inc.
Healthcare · Biotechnology
$22.48
Down-$0.85 (-3.78%)
Updated Aug 14, 2026, 10:03 PM
SID Score
6.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.26B
- P/E ratio
- -9.48
- Dividend yield
- 0.00%
- 52-week range
- $12.44 – $24.60
- Volume
- 839.45K
- Avg. volume
- 1.42M
Price performance
AMLX price history
1M range · 21 trading sessions · Daily adjusted prices
AMLX closed at $22.48 after 21 trading sessions, up 32.08% for the selected period.
- Last close
- $22.48
- Period change
- +32.08%
- Period low
- $17.02
- Period high
- $24.19
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 13, 2026 | $23.37 | $23.635 | $22.46 | $22.48 | 839.45K |
| Aug 12, 2026 | $23.86 | $24.0848 | $23.30 | $23.35 | 1.45M |
| Aug 11, 2026 | $22.78 | $23.7299 | $22.19 | $23.63 | 833.86K |
| Aug 10, 2026 | $22.68 | $23.03 | $22.00 | $22.67 | 1.33M |
| Aug 7, 2026 | $24.19 | $24.60 | $22.56 | $22.82 | 2.68M |
| Aug 6, 2026 | $21.10 | $24.36 | $21.10 | $24.19 | 3.54M |
| Aug 5, 2026 | $22.06 | $22.1694 | $21.52 | $21.85 | 1.77M |
| Aug 4, 2026 | $20.34 | $22.28 | $20.3245 | $21.87 | 3.43M |
| Aug 3, 2026 | $20.29 | $20.47 | $19.295 | $20.17 | 1.69M |
| Jul 31, 2026 | $20.74 | $20.87 | $19.295 | $20.31 | 1.83M |
| Jul 30, 2026 | $19.69 | $20.94 | $19.31 | $20.75 | 3.55M |
| Jul 29, 2026 | $19.50 | $20.21 | $19.045 | $19.73 | 2.07M |
| Jul 28, 2026 | $19.79 | $19.99 | $18.905 | $19.55 | 3.41M |
| Jul 27, 2026 | $18.50 | $19.60 | $18.08 | $19.49 | 2.58M |
| Jul 24, 2026 | $17.61 | $18.42 | $17.22 | $18.41 | 1.63M |
| Jul 23, 2026 | $17.17 | $18.035 | $17.00 | $17.59 | 816.14K |
| Jul 22, 2026 | $18.33 | $18.65 | $17.685 | $17.70 | 1.56M |
| Jul 21, 2026 | $17.44 | $18.86 | $17.38 | $18.50 | 2.72M |
| Jul 20, 2026 | $18.00 | $18.53 | $17.44 | $17.45 | 1.41M |
| Jul 17, 2026 | $16.70 | $18.08 | $16.52 | $17.75 | 1.25M |
| Jul 16, 2026 | $17.75 | $17.925 | $16.80 | $17.02 | 941.65K |
Latest AMLX news
The latest Smart Investors Daily articles mentioning AMLX.
Stock researchResearch & News · SEC Filings
Loading stock research…

